Change - Announcement of Appointment::APPOINTMENT OF MEDICAL DIRECTOR FOR THE GROUP'S IPOH CENTRE - DR SHIN HOY CHOONG

Issuer & Securities

Issuer/ Manager
ISEC HEALTHCARE LTD.
Securities
ISEC HEALTHCARE LTD. - SG1AD9000001 - 40T
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
31-Aug-2022 17:17:44
Status
New
Announcement Sub Title
APPOINTMENT OF MEDICAL DIRECTOR FOR THE GROUP'S IPOH CENTRE - DR SHIN HOY CHOONG
Announcement Reference
SG220831OTHRIS58
Submitted By (Co./ Ind. Name)
Ngiam May Ling
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Dr Shin Hoy Choong as Medical Director for the Group's Ipoh Centre

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms Ng Shi Qing, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg

Additional Details

Date Of Appointment
01/09/2022
Name Of Person
Dr Shin Hoy Choong
Age
48
Country Of Principal Residence
Malaysia
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board of Directors having reviewed and considered the qualifications of Dr Shin Hoy Choong ("Dr Shin") and upon recommendation of the Nominating Committee, is of the view that Dr Shin is suitable for the appointment of Ipoh Centre Director and has approved the appointment.
Whether appointment is executive, and if so, the area of responsibility
Executive.
Dr Shin provides supervisory role responsible for overseeing the administration and operations of the clinics under the Company's Ipoh Eye group of companies, comprising IE Centre Sdn. Bhd. and Kampar Eye Sdn. Bhd., and subscription of shares in ME Centre Sdn. Bhd., TE Centre Sdn. Bhd. and Taiping Eye Sdn. Bhd..
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Ipoh Centre Director
Professional qualifications
Bachelor of Medicine and Bachelor of Surgery (University of Malaya) Malaysia
Master of Ophthalmology (University of Malaya) Malaysia
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Dr Shin is one of the Vendors for the Group's acquisition of IE Centre Sdn. Bhd ("IE Centre") and Kampar Eye Sdn. Bhd. ("Kampar Eye"), as well as a shareholder of ME Centre Sdn Bhd ("ME Centre"), TE Centre Sdn Bhd ("TE Centre"), Taiping Eye Sdn Bhd ("Taiping Eye").

The following agreements were entered into between ISEC Sdn. Bhd. and among others Dr Shin:

1. Share Purchase and Subscription Agreement dated 6 April 2022 ("SPSA") between ISEC Sdn. Bhd. and Dr Shin, Tan Hooi Ngea, Yong Ked Sheong, Cheng Heng Liang, Chan Suet Mei, Jane Foo Mei Li, ME Centre, TE Centre and Taiping Eye;
2. Shareholders' Agreements dated 26 May 2022 in relation to ME Centre and TE Centre; and
3. Shareholders' Agreement dated 26 May 2022 in relation to Taiping Eye.

Subsequent to completing the proposed subscription, Dr Shin remains as a shareholder in ME Centre, TE Centre and Taiping Eye. Please refer to the Company's announcements dated 7 April 2022 and 26 May 2022 for details.
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
2010 to Present
Consultant Ophthalmologist/Founder
- IE Centre Sdn. Bhd.

2019 to Present
Consultant Ophthalmologist/Founder
- Kampar Eye Sdn. Bhd.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
13,127,831 ordinary shares in the capital of the Company
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
2016 to 2020
Director
- S K Zhang Agro Plantation Sdn. Bhd.
Present
2010 to Present
Executive Director
- IE Centre Sdn. Bhd.

2017 to Present
Executive Director
- Kampar Eye Sdn. Bhd.

2020 to Present
Executive Director
- ME Centre Sdn. Bhd.

2020 to Present
Executive Director
- TE Centre Sdn. Bhd.

2021 to Present
Executive Director
- Taiping Eye Sdn. Bhd.

2016 to Present
Director
- IE Properties Sdn. Bhd.

2016 to Present
Director
- IE Best Agro Sdn. Bhd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
This relates to the appointment of an Executive Officer.